Trump's birthright citizenship restrictions blocked for third time
US District Judge Leo Sorokin, joining another district court as well as an appellate panel of judges, found that a nationwide injunction granted to more than a dozen states remains in force under an exception to the Supreme Court ruling. That decision restricted the power of lower-court judges to issue nationwide injunctions.
The states have argued Trump's birthright citizenship order is blatantly unconstitutional and threatens millions of dollars for health insurance services that are contingent on citizenship status. The issue is expected to move quickly back to the nation's highest court.
White House spokeswoman Abigail Jackson said in a statement the administration looked forward to 'being vindicated on appeal.'
New Jersey Attorney General Matthew Platkin, who helped lead the lawsuit before Sorokin, said in a statement he was 'thrilled the district court again barred President Trump's flagrantly unconstitutional birthright citizenship order from taking effect anywhere.'
'American-born babies are American, just as they have been at every other time in our Nation's history,' he added. 'The President cannot change that legal rule with the stroke of a pen.'
Sorokin acknowledged his order would not be the last word on birthright citizenship.
The Trump administration has not yet appealed any of the recent court rulings. The president's efforts to deny citizenship to children born to parents who are in the country illegally or temporarily will remain blocked unless and until the Supreme Court says otherwise.
A federal judge in New Hampshire issued a ruling earlier this month prohibiting Trump's executive order from taking effect nationwide in a new class-action lawsuit. US District Judge Joseph LaPlante in New Hampshire had paused his own decision to allow for the Trump administration to appeal, but with no appeal filed, his order went into effect.
On Wednesday, a San Francisco-based appeals court found the president's executive order unconstitutional and affirmed a lower court's nationwide block.
A Maryland-based judge said last week that she would do the same if an appeals court signed off.
The justices ruled last month that lower courts generally can't issue nationwide injunctions, but it didn't rule out other court orders that could have nationwide effects, including in class-action lawsuits and those brought by states. The Supreme Court did not decide whether the underlying citizenship order is constitutional.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
LeMonde
23 minutes ago
- LeMonde
Trump shortens 50-day deadline for Russia to end war in Ukraine
US President Donald Trump said Monday, July 28 that he intends to shorten the 50-day deadline he gave Russian President Vladimir Putin to reach a deal to end the three-year war in Ukraine, after Russia continued to bombard Ukrainian cities. Russia fired an overnight barrage of more than 300 drones, four cruise missiles and three ballistic missiles, the Ukrainian air force said. Trump said two weeks ago he would implement "severe tariffs" on Russia unless a peace deal is reached by early September, as he expressed exasperation with Putin over the bombardment of Ukrainian cities amid the Republican president's attempts to stop the fighting. Trump said he would now give Putin 10 to 12 days from Monday, meaning he wants peace efforts to make progress by August 7-9. The plan includes possible sanctions and secondary tariffs targeting Russia's trading partners. The formal announcement would come later Monday or on Tuesday, he said. "No reason in waiting," Trump said of the shorter timeline. "We just don't see any progress being made." Putin has "got to make a deal. Too many people are dying," Trump said during a visit to Scotland. There was no immediate response from Russia. Trump repeated his criticism of Putin for talking about ending the war but continuing to bombard Ukrainian civilians. "And I say, that's not the way to do it," Trump said. He added, "I'm disappointed in President Putin." Asked at a news conference about a potential meeting with the Russian leader, Trump said: "I'm not so interested in talking anymore." Still, he voiced some reluctance about imposing penalties on the Kremlin, saying that he loves the Russian people. "I don't want to do that to Russia," he said, but he noted how many Russians, along with Ukrainians, are dying in the war. Ukraine has urged Western countries to take a tougher line with Putin. Andriy Yermak, the head of Ukraine's presidential office, thanked Trump for shortening the deadline. "Putin understands only strength – and that has been conveyed clearly and loudly," Yermak said on Telegram, adding that Ukrainian President Volodymyr Zelensky shared the sentiment.
Euronews
an hour ago
- Euronews
Hunger surge strikes Middle East and Africa, UN survey shows
The ongoing burden of rising global crises has exacerbated hunger in Africa, Asia and the Middle East, UN agencies warn. According to the UN's State of Food Security and Nutrition in the World 2025 report, also known as the SOFI report, trade tensions, conflicts and climate change are the primary causes of global food inflation. The report, which gathers data from five international organisations — FAO, IFAD, UNICEF, WFP, and WHO — was drafted by IFAD, a Rome-based UN agency that provides grants and low-interest loans to fund projects in developing countries. "The situation is quite alarming, especially in Africa and in the Middle East," Álvaro Lario, president of IFAD, told Euronews. "It's a mixture between the conflicts, some of the disruption or shocks caused by economic or trade tensions and also the climate shocks. These are the three main drivers," Lario explained. Since the trade tensions of 2018, during the first Trump administration, elevated tariffs have mainly remained in place, contributing to ongoing trade tensions and influencing global agricultural trade dynamics. The figures of the survey show that the proportion of the population facing hunger in Africa surpassed 20% in 2024, affecting 307 million people, while in the Middle East an estimated 12.7% of the population, or more than 39 million people, faced hunger in 2024. Small farming activities under threat Increasingly dire living conditions for small farmers and rural populations in developing countries are catalysts for economic migration flows. "It's clear, when people do not have the ability of really having a livelihood where they are, then they are forced to migrate," Lario said. The link between migration, the ability to feed oneself, and the ability to also continue producing food is clear, he added. According to UN criteria, small-scale farmers are those who exploit less than 2 hectares of land. They produce one-third of the world's food and up to 70% of the food in Africa. The economic existence and sustainability of small-scale farmers are quintessential to food supply and food security in developing countries. Yet, according to international standards, they all live under the poverty threshold. They represent 80% of the world's poorest population. According to the IFAD assessment, international aid to agriculture doesn't meet the needs of small-scale farmers: in fact, they receive less than 1% of climate finance, which amounts to slightly more than €4 billion per year, when they would need more than €70 billion. Long-term investment in agriculture and small-scale farmers in developing countries is crucial for addressing global hunger. "Africa imports approximately €70, 80 billion of food every year. Clearly, they could be self-sufficient and they could create a lot of those jobs in Africa," said Lario. Each year, approximately 10 million young Africans enter the job market. "There could be many jobs created in terms of not only production, but distribution, storage, marketing, exporting," Lario stated. Rising conflicts disrupt the food chain According to the Integrated Food Security Phase Classification (IPC), more than 35 million people are living in a state of emergency (IPC Phase 4), and almost 2 million have reached IPC Phase 5, which is categorised as "catastrophe". Places where the population is facing extreme degrees of food insecurity are the Palestinians living in the Gaza Strip, along with South Sudan, Sudan, Yemen and Haiti. The survey indicates that 100% of the population in the Gaza Strip faces high levels of acute food insecurity, affecting a total of 1,106,900 people, nearly twice the 576,000 recorded in 2023, the highest numbers ever estimated globally in IPC history. "The situation is quite alarming, especially in Africa and especially in the Middle East. I would say those are the two areas where we're saying the numbers continue to increase," concluded Lario.
Euronews
2 hours ago
- Euronews
EU-US trade deal leaves future of pharma tariffs uncertain
The current status of tariffs on pharmaceuticals between the EU and the US remains uncertain, despite the announcement on Sunday of a new transatlantic trade agreement. The situation is particularly sensitive given the mutual dependency in the sector: the US imports large volumes of critical pharmaceuticals from the EU, while EU-based pharmaceutical companies—especially in Ireland and Denmark—rely heavily on access to the American market. Although the new trade agreement will officially enter into force on 1 August, pharmaceuticals will not be subject to a 15% tariff which will be slapped on most goods imported from the European Union to the United States. This does not mean that there won't be tariffs at all on pharmaceuticals, as the US is still conducting an investigation into imported pharmaceuticals to assess whether they threaten US national security. For this reason, pharmaceuticals were technically excluded from yesterday's formal agreement, several EU sources confirm, as the US could not commit to any decision on tariff changes, which will only come after the conclusion of that process. However, if tariffs are introduced following the investigation, the EU expects the US—under President Trump—to honour the informal understanding reached during negotiations. This includes a cap of 15% on tariffs, which the EU considers "all-inclusive", meaning it should apply even to products still under investigation, such as pharmaceuticals and semiconductors. 'I believe that this commitment will be honoured and respected in this case as well,' said EU Trade Commissioner Maroš Šefčovič during a press briefing following the deal. So, what happens after 1 August? In the short term, nothing will change. Despite earlier reports suggesting the US would impose a 15% tariff on pharmaceuticals too in line with most EU goods, that is not expected to happen immediately. 'There will be no tariffs on pharmaceuticals this Friday,' clarified a senior EU official who participated in the negotiations with President Trump in Scotland. Most pharmaceutical products traded between the EU and the US currently benefit from a 0% tariff rate under the Most-Favoured Nation (MFN) framework. This is consistent with prior US-EU trade arrangements and World Trade Organization (WTO) commitments. As a result, EU pharmaceutical exports have faced no tariff barriers when entering the US market—a condition that remained unchanged even after Trump's so-called "Liberation Day", when he announced imposing blanket tariffs on goods. Uncertain outcome of the US investigation But tariffs on pharmaceuticals are expected to come at one point. The key uncertainty revolves around the ongoing Section 232 investigation being conducted by the Trump administration. This probe, authorised under the Trade Expansion Act of 1962, is intended to assess whether imports of pharmaceuticals (and other products as well such as semiconductors) threaten US national security. The investigation's conclusions could lead to unilateral actions by the US, including higher tariffs or import restrictions, independent of the broader trade deal struck yesterday. '[During the talks] President Trump wanted to make clear that they still have full freedom to conclude the 232 investigations and to choose any policy measures as a result,' said another EU negotiator. While EU officials cannot predict the outcome of the US investigation, they believe it is nearing completion. 'These are two investigations—pharmaceuticals and semiconductors—that are pretty close to conclusion,' an official noted. If the US does impose tariffs following the investigation, the EU expects these to be capped at 15% for both sectors, in line with the political understanding reached during the trade talks. EU's bet on pharma tariffs The EU's strategy is clear: even though Trump could not legally commit yesterday to tariffs on pharmaceuticals while the investigation is ongoing, the EU insisted on a 15% ceiling across all sectors, with no exclusions for pharmaceuticals. A senior EU official added that this understanding is backed by a broader political commitment, including planned investments by pharmaceutical companies in the US and pressure from the industry on both sides of the Atlantic to collaborate more closely. 'There is a clear understanding that investments, supply chain integration, and joint R&D efforts should all fall under the special 15% regime,' the official explained. Still, the EU acknowledges that this is not yet a legally binding commitment. 'Is this a legal commitment? No, not at this stage. That would have to come through an executive order once the US concludes its investigation,' the source continued. For now, both pharmaceutical and semiconductor products remain at zero-duty 0rates. No changes will occur on 1 August, but that could change once the US finalises its Section 232 investigation.
